|
| 菲沃泰(688371)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-08-04 | 20853.33 | 62.16% | 33547.24 | 0.00 | 12693.90 | 37.84% | 首发原股东限售股份 | | 2024-08-02 | 323.62 | 0.96% | 12693.90 | 20853.33 | 12399.36 | 36.96% | 首发战略配售股份 | | 2023-12-29 | 1853.76 | 5.53% | 12370.28 | 21176.96 | 7879.37 | 23.49% | 首发原股东限售股份 | | 2023-10-27 | 1594.67 | 4.75% | 10516.52 | 23030.72 | 7879.37 | 23.49% | 首发原股东限售股份 | | 2023-10-23 | 858.67 | 2.56% | 8921.85 | 24625.38 | 7879.37 | 23.49% | 首发原股东限售股份 | | 2023-08-02 | 232.39 | 0.69% | 8063.18 | 25484.05 | 7879.37 | 23.49% | 首发战略配售股份 | | 2023-02-02 | 381.63 | 1.14% | 7879.37 | 25667.87 | 7879.37 | 23.49% | 首发机构配售股份 | | 2022-08-02 | 7449.16 | 22.20% | 7449.16 | 26098.07 | 7449.16 | 22.20% | 首发一般股份 |
|